KY-001

N/A

Report date: 2024/11/20 14:15:31

NME

Base Information

Drug NameKY-001

Drug Alias NameKY-001KY001

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTranscriptional enhancer factor TEF-3 inhibitorsTranscriptional enhancer factor TEF-1 inhibitorsTranscriptional enhancer factor TEF-4 inhibitors +[4]

TargetsTranscriptional enhancer factor TEF-3Transcriptional enhancer factor TEF-1Transcriptional enhancer factor TEF-4 +[4]

Therapy Area/IndicationsSolid tumoursMesothelioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesShanghai Kygent Therapeutics Co LTD

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Kygent Therapeutics Co LTD

Inactive CompaniesN/A

Active IndicationsSolid tumoursMesothelioma

Inactive IndicationsN/A

Other Information

ATC CodeN/A